Newsletter Signup | Community
Recent suggests that combining an immune PD-1 checkpoint inhibitor with a TKI to treat advanced RCC is promising.
Combination of precision cancer medicines may represent new treatment strategy for advanced renal cell cancer.
Cancer Connect - Treatment of Recurrent Kidney Cancer
COMETRIQ® Improves Progression-Free Survival in Kidney Cancer
Siblings of Kidney Cancer Patients at Increased Risk for the Disease.
Precision cancer medicines and immunotherapy is the mainstay of stage IV Kidney Cancer treatment.
Cancer Connect - Treatment of Stages I - III Kidney Cancer